Retatrutide was working, so why did I stop
Retatrutide was working. Food noise was dramatically reduced. My training consistency was the best it had ever been. Energy was high. By almost every subjective measure, my experience was positive.
I stopped anyway.
Not because of a bad reaction. Not because the results faded. But because two specific numbers in my health data had been moving in the wrong direction for long enough that I could not ignore them anymore. And I think understanding why I made this decision will give you some of the most important information to have before considering any peptide in this class.
For context: I recently had a full blood panel done and a full body preventative MRI. My overall health picture is excellent. This is not a panic decision. It is a data-driven one.
What retatrutide actually did, the honest recap
If you have followed this peptide series from the beginning, you will know the headline results. But the full picture matters here because context shapes everything that follows.
The food noise change was the most significant thing I experienced. I eat to procrastinate. I have done it my whole life. On retatrutide that pull just stopped, not completely, but dramatically. The thought would come up and it simply did not have the same grip. I could eat two bites of something and put it down, something I have genuinely never been able to do before.
Training consistency has been the best it has ever been. Workouts not skipped in months. Protein targets consistently hit. Recovery feeling deliberate rather than reactive.
Energy was high. Motivation was high. The first few weeks had some sleep disruption related to elevated ketones from the glucagon mechanism, but that settled once I adjusted carbohydrate intake.
By almost every subjective measure, this has been a positive experience. Which is exactly what makes the next part worth paying attention to.
The two numbers that changed my decision
Resting heart rate and HRV. These are two of the most reliable markers of cardiovascular health and nervous system recovery available through consumer wearables. Both of mine moved significantly in the wrong direction after starting retatrutide.
Resting heart rate. Mine increased by approximately 10 beats per minute. Resting heart rate reflects how efficiently your heart is working at rest. A lower number generally indicates better cardiovascular fitness and heart efficiency. An increase of 10 beats is not noise. It is a meaningful and sustained shift that held over months, not days.
Heart rate variability (HRV). Mine dropped from an average of around 80 milliseconds down to the mid-thirties. HRV measures the variation in time between heartbeats and reflects how well your autonomic nervous system is adapting to stress and recovery. Higher is generally better. A drop of that magnitude is significant.
I want to be honest about my relationship with HRV data because I think it matters. Day to day variability is real and the signal can be noisy. Changes across the menstrual cycle alone can frustrate interpretation. HRV naturally drops in the luteal phase and that can skew averages significantly.
But here is what I kept coming back to. The last time I saw a significant HRV drop, it turned out I was low in iron. When I corrected my iron stores, it came back up. So there is something to it as a signal even when the day to day data is imperfect.
A 10 beat increase in resting heart rate sustained over months, combined with an HRV drop of that magnitude, is not something I can attribute to cycle phase or a bad week. And I can feel it. When I train, particularly in hockey, I can feel my heart rate running higher than it should for the effort I am putting in. That is the thing I cannot dismiss.
Why I am not panicking, but I am stopping
The full context matters here.
My recent comprehensive blood panel came back excellent across every marker that matters: lipids, inflammation markers, metabolic panel, hormones. Everything in a healthy range. My full body preventative MRI, which I had done as part of proactive monitoring rather than out of concern, came back completely clear.
So this is not a situation where my health is compromised. It is a situation where two specific markers are trending in the wrong direction and I am choosing to act on that before it becomes a problem rather than after.
That is the whole point of monitoring. Not waiting until something is wrong. Catching the signal early and making an informed decision.
Retatrutide was working. But the cardiovascular signals were telling me my body was under more stress than I am comfortable with long term. And that is enough.
What I am switching to and why
I am not walking away from peptides in this class entirely. What I am considering switching to is a microdose of tirzepatide, and the difference between the two matters.
Tirzepatide is a dual agonist targeting GLP-1 and GIP receptors. Retatrutide is a triple agonist, adding glucagon on top of that. The glucagon component is what drives the more aggressive fat loss data with retatrutide, and it is also what elevates ketones and shifts metabolism more dramatically.
For someone whose primary goal is significant weight loss, retatrutide's triple mechanism is more powerful. But that was never my goal. My goal was the food noise and the behaviour change. Tirzepatide's dual mechanism should address that without the glucagon-driven cardiovascular stress I experienced on retatrutide.
The trade-off is that tirzepatide is less aggressive metabolically. No glucagon means less ketone elevation and less of the dramatic fat-burning shift. For me right now, that is an acceptable trade. I will report back when I have enough data to say something meaningful.
What this means for anyone considering these peptides
These peptides are powerful tools. The GLP-1 class specifically has genuinely changed how I think about behaviour change and food noise in a way that no amount of discipline or habit stacking ever did for me.
But powerful tools require monitoring. Not fear, monitoring. If you are using any peptide in this class and you are not tracking your resting heart rate and HRV, you are missing data that matters. A consumer wearable is enough. You do not need clinical equipment. You just need a baseline and consistency.
And if your numbers are moving in the wrong direction, even if you feel good, even if results are coming, take it seriously. Feeling good is not the same as all systems functioning optimally. That gap is exactly what data is for.
Key takeaways
Retatrutide produced significant subjective benefits including reduced food noise, improved training consistency, and high energy
Resting heart rate increased by approximately 10 beats per minute sustained over months, not days
HRV dropped from around 80 milliseconds to the mid-thirties, a significant shift in autonomic nervous system recovery
Blood panel and full body MRI results were excellent, this was a proactive decision not a crisis response
The glucagon mechanism in retatrutide that drives aggressive fat loss may also be the source of cardiovascular stress in some users
Tirzepatide (dual agonist, no glucagon) is the next consideration for maintaining food noise benefits with a lower cardiovascular load
Anyone using peptides in this class should be tracking resting heart rate and HRV consistently with a consumer wearable
FAQ
Why did you stop taking retatrutide if it was working? Two cardiovascular markers, resting heart rate and HRV, moved significantly in the wrong direction over a sustained period. Resting heart rate increased by around 10 beats per minute and HRV dropped from approximately 80 milliseconds to the mid-thirties. Those signals, combined with a noticeable difference during training, were enough to make a data-driven decision to stop.
Is retatrutide dangerous? This is not a conclusion I am drawing from my experience. My blood panel and full body MRI were excellent. What I experienced was a specific cardiovascular response that I was not comfortable continuing with long term. Individual responses vary, and monitoring is essential for anyone using peptides in this class.
What is the difference between retatrutide and tirzepatide? Tirzepatide targets two receptors, GLP-1 and GIP. Retatrutide targets three, adding glucagon. The glucagon component drives more aggressive fat loss and metabolic shifting but also appears to place more cardiovascular demand on the body in some users.
Should I track HRV if I am using a GLP-1 peptide? Yes. Resting heart rate and HRV are two of the most accessible and reliable indicators of cardiovascular and nervous system health available through consumer wearables. Establishing a baseline before starting and monitoring consistently throughout gives you meaningful data to make informed decisions.
What is food noise and do GLP-1 peptides actually reduce it? Food noise refers to the constant mental preoccupation with food, cravings, and eating urges that many people experience. In my experience, and consistent with what many others report, GLP-1 peptides significantly reduce this mental chatter. It is one of the most underreported benefits of this class of peptides.
Conclusion
Retatrutide delivered real results. The food noise reduction alone was unlike anything I had experienced through diet or habit work. But two cardiovascular markers told a different story, and I chose to listen to the data rather than the results.
That is what proactive health monitoring actually looks like in practice. Watch the full YouTube video for the complete breakdown including the blood panel context and the full reasoning behind the switch to tirzepatide. If you have questions about peptides or your own experience with this class, drop them in the comments.
